The next step for Burkitt lymphoma - Wikidata - wikimedia - TriplyDB

The next step for Burkitt lymphoma

The next step for Burkitt lymphoma

http://www.wikidata.org/entity/Q42785005

about

The next step for Burkitt lymphoma

http://www.wikidata.org/entity/Q42785005

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

The next step for Burkitt lymphoma

@en

The next step for Burkitt lymphoma

@nl

type

label

The next step for Burkitt lymphoma

@en

The next step for Burkitt lymphoma

@nl

prefLabel

The next step for Burkitt lymphoma

@en

The next step for Burkitt lymphoma

@nl

P1433

Q42785005-89289E72-B380-4219-952A-7E215BABF0A5

P1476

Q42785005-D7B7B169-D852-4ABC-B056-E2415693E3E1

P2093

Q42785005-15FCF215-5320-42F9-822B-9AF9B7B36408

P2860

Q42785005-32D9E92F-9B2E-4527-A467-FDCACF7C77F8

Q42785005-4377259F-BF26-47F0-B690-0B5CC734394A

Q42785005-5DD1A0BD-77F5-49A9-8388-C6961403270A

Q42785005-6778C2DB-4EE4-4563-A6D5-143224A79CFC

Q42785005-89B4A572-2AA0-4C01-B26E-B1CD5D68FD26

Q42785005-C5F8ABDD-08B7-4912-BE99-E099BF08F663

Q42785005-E4CB35A5-886B-4C19-AF95-D4280E2F18AF

P304

Q42785005-F446A5FA-0154-4250-9235-CDD04ADF7E4A

P31

Q42785005-CBB79758-8B76-4017-A22F-62777D1395AF

Q42785005-a32899c1-9e0b-4083-80f2-26b82eef8f0c

P356

Q42785005-00A35F6F-B67D-43C1-9DDC-CD72084E78B5

P433

Q42785005-1C752196-0612-4E51-9F33-C61DEFAFEDFA

P478

Q42785005-64039132-9F46-4D33-A025-0208C71BE010

P577

Q42785005-DC0C6961-32AC-4C7F-94E5-16985A08C7FF

P5875

Q42785005-B114CB65-530C-46E6-A509-D840589004A3

P698

Q42785005-960DFE9D-85EE-45DB-AB40-4FF9E2422E18

P921

Q42785005-9552E9E0-6832-41D6-B2BC-31423C318B6C

P932

Q42785005-0B0B8A51-BD77-46E4-A422-FBAF9A173F11

P356

KJH.2011.46.2.60

P1433

The Korean Journal of Hematology

P1476

The next step for Burkitt lymphoma

@en

P2093

Bin Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.

Treatment of mature B-ALL and high grade B-NHL in children.

Treatment outcomes in children with Burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institution.

Diffuse large B-cell lymphomas and burkitt lymphoma.

Burkitt lymphoma/leukemia: improving prognosis.

Advances in the understanding of MYC-induced lymphomagenesis.

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.

P304

60-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5045/KJH.2011.46.2.60

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51484481

http://www.w3.org/2001/XMLSchema#string

P698

21747873

http://www.w3.org/2001/XMLSchema#string

P921

Burkitt lymphoma

P932

3128899

http://www.w3.org/2001/XMLSchema#string